Ainos, Inc. (NASDAQ:AIMDW) Sees Large Decline in Short Interest

Ainos, Inc. (NASDAQ:AIMDW) was the target of a large decline in short interest during the month of June. As of June 15th, there was short interest totaling 3,220 shares, a decline of 52.8% from the May 31st total of 6,829 shares. Based on an average daily volume of 2,622 shares, the short-interest ratio is presently 1.2 days.

Ainos Price Performance

Ainos stock opened at $0.12 on Thursday. Ainos has a one year low of $0.05 and a one year high of $0.95. The company’s fifty day moving average price is $0.10 and its two-hundred day moving average price is $0.11.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.